Collegium Pharmaceutical Interest Expense 2011-2026 | COLL

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Collegium Pharmaceutical

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	21 M	28.9 M	909 K	20.1 M	582 K	94 K	439 K	252 K	-155 K	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
28.9 M	-155 K	8.02 M

Quarterly Interest Expense Collegium Pharmaceutical

2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	-	-	20.8 M	21.9 M	21.4 M	-	19 M	17.8 M	5.83 M	4.76 M	5.12 M	5.42 M	5.72 M	7.74 M	8.06 M	8.26 M	4.82 M	211 K	228 K	236 K	234 K	2.4 M	5.87 M	6.16 M	5.7 M	180 K	167 K	137 K	98 K	20 K	2 K	46 K	-66 K	-89 K	97 K	99 K	-64 K	-142 K	-51 K	-29 K	-29 K	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
21.9 M	-142 K	4.68 M

Interest Expense of other stocks in the Biotechnology industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	4.66 M	-	2.43 %	$ 254 M	Germany
AbCellera Biologics ABCL	-2.71 M	$ 3.54	-0.7 %	$ 1.06 B	Canada
Acorda Therapeutics ACOR	31.5 M	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	28 K	-	-9.65 %	$ 45.9 M	USA
AC Immune SA ACIU	1.89 M	$ 3.25	3.83 %	$ 229 M	Schweiz
I-Mab IMAB	722 K	-	-	$ 866 M	China
Aeglea BioTherapeutics AGLE	29.5 M	-	-	$ 1.01 B	USA
AgeX Therapeutics AGE	4.9 M	-	-10.17 %	$ 12.2 K	USA
Albireo Pharma ALBO	3.69 M	-	-0.23 %	$ 916 M	USA
Aileron Therapeutics ALRN	685 K	-	10.36 %	$ 9.8 M	USA
Adverum Biotechnologies ADVM	8.23 M	-	-	$ 86.2 M	USA
Ascendis Pharma A/S ASND	80.6 M	$ 228.93	-0.91 %	$ 5 B	Danmark
Alterity Therapeutics Limited ATHE	2.28 K	$ 3.39	-6.09 %	$ 8.16 B	Australia
Applied Genetic Technologies Corporation AGTC	2.67 M	-	-	$ 26.5 M	USA
Applied Molecular Transport AMTI	-4 K	-	-	$ 10.1 M	USA
Arcturus Therapeutics Holdings ARCT	10.1 M	$ 6.62	-0.15 %	$ 181 M	Israel
BioCardia BCDA	3 K	$ 1.35	6.29 %	$ 28.6 M	USA
Akero Therapeutics AKRO	4.67 M	-	-	$ 3.67 B	USA
Athersys ATHX	103 K	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	-1.72 M	-	0.23 %	$ 488 M	USA
Acer Therapeutics ACER	432 K	-	2.71 %	$ 14 M	USA
ARCA biopharma ABIO	9 K	-	1052.0 %	$ 415 M	USA
Allena Pharmaceuticals ALNA	-38 K	-	3.16 %	$ 1.9 M	USA
AlloVir ALVR	1.19 M	-	4.14 %	$ 49.1 M	USA
Can-Fite BioPharma Ltd. CANF	227 K	$ 3.58	-0.28 %	$ 7.79 B	Israel
Catalyst Biosciences CBIO	-1.5 M	$ 11.29	-2.51 %	$ 1.01 B	USA
Aptinyx APTX	737 K	-	-39.0 %	$ 4.57 M	USA
CNS Pharmaceuticals CNSP	7.03 K	$ 2.32	-5.51 %	$ 887 K	USA
AVEO Pharmaceuticals AVEO	1.6 M	-	-	$ 521 M	USA
Aytu BioScience AYTU	-512 K	$ 2.69	1.7 %	$ 16.9 M	USA
Curis CRIS	890 K	$ 0.89	3.74 %	$ 5.61 M	USA
Avenue Therapeutics ATXI	294 K	-	-52.27 %	$ 4.45 M	USA
BioNTech SE BNTX	14.2 M	$ 93.04	2.76 %	$ 27.2 B	Germany
Autolus Therapeutics plc AUTL	9.29 M	$ 1.51	-0.33 %	$ 385 M	Britain
Athira Pharma ATHA	3.96 M	-	-	$ 269 M	USA